UPMC CancerCenters, Hilman Cancer Center

5115 Centre Avenue
Pittsburgh, Pennsylvania 15232

We've found

1 trials

at this facility

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Pittsburgh, PA

Use our guide to learn which trials are right for you!